- Home
- MLEC vs DYAI Comparison
MLEC vs DYAI Comparison
Compare MLEC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLEC
- DYAI
- Stock Information
- Founded
- MLEC 2008
- DYAI 1979
- Country
- MLEC Luxembourg
- DYAI United States
- Employees
- MLEC N/A
- DYAI N/A
- Industry
- MLEC Blank Checks
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MLEC Finance
- DYAI Health Care
- Exchange
- MLEC Nasdaq
- DYAI Nasdaq
- Market Cap
- MLEC 32.8M
- DYAI 31.5M
- IPO Year
- MLEC N/A
- DYAI 2004
- Fundamental
- Price
- MLEC $0.85
- DYAI $1.14
- Analyst Decision
- MLEC Strong Buy
- DYAI Strong Buy
- Analyst Count
- MLEC 1
- DYAI 1
- Target Price
- MLEC $6.00
- DYAI $6.00
- AVG Volume (30 Days)
- MLEC 11.2K
- DYAI 17.1K
- Earning Date
- MLEC 12-12-2024
- DYAI 11-12-2024
- Dividend Yield
- MLEC N/A
- DYAI N/A
- EPS Growth
- MLEC N/A
- DYAI N/A
- EPS
- MLEC N/A
- DYAI N/A
- Revenue
- MLEC $5,625,124.00
- DYAI $3,364,548.00
- Revenue This Year
- MLEC $20.42
- DYAI $2.04
- Revenue Next Year
- MLEC $30.00
- DYAI $110.34
- P/E Ratio
- MLEC N/A
- DYAI N/A
- Revenue Growth
- MLEC 521.53
- DYAI 13.82
- 52 Week Low
- MLEC $0.75
- DYAI $0.93
- 52 Week High
- MLEC $3.25
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- MLEC 46.82
- DYAI 53.97
- Support Level
- MLEC $0.83
- DYAI $1.02
- Resistance Level
- MLEC $0.91
- DYAI $1.15
- Average True Range (ATR)
- MLEC 0.04
- DYAI 0.08
- MACD
- MLEC -0.00
- DYAI 0.01
- Stochastic Oscillator
- MLEC 52.06
- DYAI 93.38
About MLEC Moolec Science SA
Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.